top of page

Description

Animal growth promoters and performance enhancers are type of chemicals and drugs which enhance the growth of animals. Majorly these enhancers help to digest food more effectively and enable animals to grow faster which improves the productivity of the animals. In addition to this these chemicals and drugs provide protection against various type of microbial diseases among animals. Animal growth promoters and performance enhancers market is growing rapidly due to increasing focus on poultry, livestock and agriculture sector across the world.  Globally these drugs are used as growth supplements for the animals’ weight increase. These supplements also increase the productivity of the animals by increasing the production of milk ruminants. The global animal growth promoters and performance enhancers market is driven by growing consumption of meat across the world and increasing disposable income of the people. In addition to this the growing population across the world also fuel the demand for food from animal sources. 
The animal growth promoters and performance enhancers market report include various segments including 
•    Animal Type
o    Poultry
o    Swine,
o    Livestock
o    Aquatic animals
Other animals
•    Type of Drug/Chemicals  
o    Antibiotics
o    Non-Antibiotics 
    Prebiotics & Probiotics
    Phytogenics
    Feed Enzymes
    Hormones
•    Region
o    North America
o    Europe
o    APAC
o    RoW
In the animal type segment, the poultry segment accounted largest market share in animal growth promoters and performance enhancers market due to increasing demand for meat and egg, and advanced diet plans in poultry farming. 
Further, based on the type of chemical/drug segment the non-antibiotic segment accounted largest share in the animal growth promoters and performance enhancers market due to its economic benefits, wide range of substances, environmental sustainability and increasing regulations on antibiotics and hormones. 
Moreover, animal growth promoters and performance enhancers market segmented by four regions including North America, Europe, APAC, and RoW. Further the regional analysis includes country level analysis for animal growth promoters and performance enhancers. Asia Pacific is one of the major contributors in the market due to high population as well as large number of animal product companies in this region. North America is accounted second largest share in the market due to increasing awareness about animal growth and performance enhancers and increase in livestock population.  

Globally the animal growth promoters and performance enhancers market is growing at CAGR of ~ 6.2% during the forecast period of 2020-2026. There are two major factors are driving the market such as increasing research and development practices to develop antibiotics & hormones and non-antibiotic growth enhancers and rise in climate change and animal epidemics. 
Globally these animal growth promoters and performance enhancers plays an important role in agricultural sector due increasing income from the livestock and poultry farming.  Which increase the demand for animal growth promoters and performance enhancers. However, the stringent government rules and regulations in some regions for animal growth promoters and performance enhancers hinders the demand for animal growth promoters and performance enhancers. 
The report also includes the analysis of major players in the animal growth promoters and performance enhancers market. Some of the major players consists of Elanco Animal Health Inc, Royal DSM N.V, Cargill, Inc, Merck & Co., Inc, Alltech, Inc, Vetoquinol, Bupo Animal Health, Archer-Daniels-Midland Company (ADM), Chr. Hansen, Novus International, Inc, Erber AG, Kemin Industries, Associated British Foods PLC, Nutreco, Erber AG, BASF SE, Phibro Animal Health Corporation, Evonik Industries AG, Bluestar Adisseo Company, Land O’lakes, Inc. and, Lallemand Inc.
Lack of awareness among end-users about animal growth promoters & performance enhancers is the major challenges for the market. However, the increasing investment in research and development activities for the development of natural growth promoters & performance enhancers give new opportunities for the market players in the animal growth promoters and performance enhancers market to solidify their presence. This report will help the market players to understand the key market trends, market dynamics, and dynamic need of the end-users. The qualitative and quantitative analysis enhances the user experience of the report. 
●    The competitive analysis of the major players enables users to understand the dynamic strategies such as product innovation, partnerships, merger & acquisitions and joint ventures of the key players
●    This report also provides the SWOT analysis, portfolio analysis, capability analysis of the leading players  
●    The report will also help the research organization of Animal Growth Promoters and Performance Enhancers to support their drug discovery and development activities
●    Quantitative analysis of the market enables users to understand the actual facts of the market across four major regions

Animal Growth Promoters and Performance Enhancers Market Forecast up to 2028

4٬500٫00$السعر
  • Table of Contents

    1.    Executive Summary
    2.    Industry Outlook

    2.1.    Industry Overview
    2.2.    Industry Trends
    3.    Market Snapshot
    3.1.    Market Definition
    3.2.    Market Outlook
    3.2.1.    Porter Five Forces
    3.3.    Related Markets
    4.    Market characteristics
    4.1.    Market Overview
    4.2.    Market Segmentation
    4.3.    Market Dynamics
    4.3.1.    Drivers
    4.3.2.    Restraints
    4.3.3.    Opportunities
    4.4.    DRO - Impact Analysis
    5.    Animal Type: Market Size & Analysis
    5.1.    Overview
    5.2.    Poultry
    5.3.    Swine
    5.4.    Livestock
    5.5.    Aquatic animals
    5.6.    Other animals
    6.    Type of Drug/Chemicals: Market Size & Analysis
    6.1.    Overview
    6.2.    Antibiotics
    6.3.    Non-Antibiotics
    7.    Geography: Market Size & Analysis
    7.1.    Overview
    7.2.    North America
    7.3.    Europe
    7.4.    Asia Pacific
    7.5.    Rest of the World
    8.    Competitive Landscape
    8.1.    Competitor Comparison Analysis
    8.2.    Market Developments
    8.2.1.    Mergers and Acquisitions, Legal, Awards, Partnerships
    8.2.2.    Product Launches and execution
    9.    Vendor Profiles
    9.1.    Cargill, Inc.
    9.1.1.    Overview
    9.1.2.    Financial Overview
    9.1.3.    Product Offerings
    9.1.4.    Developments
    9.1.5.    Business Strategy
    9.2.    Zoetis Inc.
    9.2.1.    Overview
    9.2.2.    Financial Overview
    9.2.3.    Product Offerings
    9.2.4.    Developments
    9.2.5.    Business Strategy
    9.3.    Royal DSM N.V.
    9.3.1.    Overview
    9.3.2.    Financial Overview
    9.3.3.    Product Offerings
    9.3.4.    Developments
    9.3.5.    Business Strategy
    9.4.    Elanco Animal Health
    9.4.1.    Overview
    9.4.2.    Financial Overview
    9.4.3.    Product Offerings
    9.4.4.    Developments
    9.4.5.    Business Strategy
    9.5.    Alltech Corporation
    9.5.1.    Overview
    9.5.2.    Financial Overview
    9.5.3.    Product Offerings
    9.5.4.    Developments
    9.5.5.    Business Strategy
    9.6.    Archer Daniels Midland Company
    9.6.1.    Overview
    9.6.2.    Financial Overview
    9.6.3.    Product Offerings
    9.6.4.    Developments
    9.6.5.    Business Strategy
    9.7.    Boehringer Ingelheim Animal Health GmbH
    9.7.1.    Overview
    9.7.2.    Financial Overview
    9.7.3.    Product Offerings
    9.7.4.    Developments
    9.7.5.    Business Strategy
    9.8.    Evonik Industries AG
    9.8.1.    Overview
    9.8.2.    Financial Overview
    9.8.3.    Product Offerings
    9.8.4.    Developments
    9.8.5.    Business Strategy
    9.9.    Kemin Industries, Inc.
    9.9.1.    Overview
    9.9.2.    Financial Overview
    9.9.3.    Product Offerings
    9.9.4.    Developments
    9.9.5.    Business Strategy
    9.10.    Phibro Animal Health Corporation
    9.10.1.    Overview
    9.10.2.    Financial Overview
    9.10.3.    Product Offerings
    9.10.4.    Developments
    9.10.5.    Business Strategy
    10.    Analyst Opinion
    11.    Annexure

    11.1.    Report Scope
    11.2.    Market Definitions
    11.3.    Research Methodology
    11.3.1.    Data Collation and In-house Estimation
    11.3.2.    Market Triangulation
    11.3.3.    Forecasting
    11.4.    Report Assumptions
    11.5.    Declarations
    11.6.    Stakeholders
    11.7.    Abbreviations

  • LinkedIn
  • Twitter
  • Twitter
  • Linkedin
bottom of page